Published in J Pharmacol Exp Ther on June 01, 1999
Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev (2009) 5.64
Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol (2009) 4.16
Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) (2006) 3.68
It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol (2007) 2.85
Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol (2009) 1.76
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J (2009) 1.68
Review. Neurobiology of nicotine dependence. Philos Trans R Soc Lond B Biol Sci (2008) 1.62
Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci (2005) 1.59
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction. Biochem Pharmacol (2007) 1.49
α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev (2011) 1.29
Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci (2009) 1.23
Nicotinic receptors as CNS targets for Parkinson's disease. Biochem Pharmacol (2007) 1.21
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J Pharmacol Exp Ther (2011) 1.15
Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl) (2005) 1.14
Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry (2011) 1.14
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline. Nicotine Tob Res (2010) 1.13
Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders. Biochem Pharmacol (2011) 1.12
Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci (2012) 1.12
Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms. J Neural Transm (Vienna) (2006) 1.11
Tobacco smoke exposure induces nicotine dependence in rats. Psychopharmacology (Berl) (2009) 1.11
Naturally-expressed nicotinic acetylcholine receptor subtypes. Biochem Pharmacol (2011) 1.10
Treating tobacco dependence in a medical setting. CA Cancer J Clin (2009) 1.08
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav Neurosci (2008) 1.07
Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunits. Neuropharmacology (2011) 1.07
Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience (2005) 1.05
Protein kinases and addiction. Ann N Y Acad Sci (2008) 1.05
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy. Pharmacol Ther (2009) 1.04
Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions. Front Mol Neurosci (2012) 1.04
Evaluation of F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imaging. EJNMMI Res (2011) 1.00
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. J Pharmacol Exp Ther (2012) 0.99
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav (2007) 0.99
Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. Nicotine Tob Res (2005) 0.98
Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiol Aging (2008) 0.98
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacology (2007) 0.96
86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization. Biochem Pharmacol (2010) 0.95
Regulatory strategies to reduce tobacco addiction in youth. Tob Control (2003) 0.92
PET imaging of α4β2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. J Nucl Med (2012) 0.90
The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function. Neuropharmacology (2015) 0.90
Alterations in cholinergic sensitivity of respiratory neurons induced by pre-natal nicotine: a mechanism for respiratory dysfunction in neonatal mice. Philos Trans R Soc Lond B Biol Sci (2009) 0.89
Inside-out neuropharmacology of nicotinic drugs. Neuropharmacology (2015) 0.89
Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons. J Neurochem (2011) 0.88
Long-term upregulation of protein kinase A and adenylate cyclase levels in human smokers. J Neurosci (2007) 0.88
α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration. J Neurochem (2014) 0.85
Impact of sustained exposure to β-amyloid on calcium homeostasis and neuronal integrity in model nerve cell system expressing α4β2 nicotinic acetylcholine receptors. J Biol Chem (2013) 0.85
Acetylcholine release and inhibitory interneuron activity in hippocampal CA1. Front Synaptic Neurosci (2014) 0.85
Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins. Structure (2016) 0.85
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers. Synapse (2009) 0.84
Choline promotes nicotinic receptor alpha4 + beta2 up-regulation. J Biol Chem (2010) 0.84
Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. Genes Brain Behav (2015) 0.84
A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) (2013) 0.83
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors. J Pharmacol Exp Ther (2014) 0.82
The possible contribution of neuronal nicotinic acetylcholine receptors in depression. Dialogues Clin Neurosci (2005) 0.81
Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. J Child Adolesc Psychopharmacol (2012) 0.81
Regulation of the distribution and function of [(125)I]epibatidine binding sites by chronic nicotine in mouse embryonic neuronal cultures. J Pharmacol Exp Ther (2012) 0.81
Mechanisms of Inhibition and Potentiation of α4β2 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family. J Biol Chem (2015) 0.80
Targeting nicotinic receptors for Parkinson's disease therapy. CNS Neurol Disord Drug Targets (2011) 0.80
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain. J Neurochem (2014) 0.80
Baseline impulsive choice predicts the effects of nicotine and nicotine withdrawal on impulsivity in rats. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.79
Acetylcholine release in mouse hippocampal CA1 preferentially activates inhibitory-selective interneurons via α4β2* nicotinic receptor activation. Front Cell Neurosci (2015) 0.78
RIC-3 differentially modulates α4β2 and α7 nicotinic receptor assembly, expression, and nicotine-induced receptor upregulation. BMC Neurosci (2013) 0.78
Genetic matters: thirty years of progress using mouse models in nicotinic research. Biochem Pharmacol (2013) 0.78
Chronic treatment with varenicline changes expression of four nAChR binding sites in mice. Neuropharmacology (2015) 0.78
Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure. Pharmacol Res Perspect (2015) 0.78
Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice. Psychopharmacology (Berl) (2014) 0.78
Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test. Psychopharmacology (Berl) (2009) 0.77
Down-regulation of Decapping Protein 2 mediates chronic nicotine exposure-induced locomotor hyperactivity in Drosophila. PLoS One (2012) 0.77
Chronic nicotine pretreatment is sufficient to upregulate α4* nicotinic receptors and increase oral nicotine self-administration in mice. BMC Neurosci (2014) 0.77
Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors. J Biol Chem (2011) 0.77
Regulation of α4β2α5 nicotinic acetylcholinergic receptors in rat cerebral cortex in early and late adolescence: Sex differences in response to chronic nicotine. Neuropharmacology (2015) 0.77
Spectral confocal imaging of fluorescently tagged nicotinic receptors in knock-in mice with chronic nicotine administration. J Vis Exp (2012) 0.77
Effects of adolescent nicotine exposure and withdrawal on intravenous cocaine self-administration during adulthood in male C57BL/6J mice. Addict Biol (2012) 0.77
Prenatal nicotine exposure enhances the trigeminocardiac reflex via serotonin receptor facilitation in brainstem pathways. J Appl Physiol (1985) (2013) 0.76
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates. Psychopharmacology (Berl) (2016) 0.76
Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. J Nucl Med (2015) 0.76
Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. Int J Neuropsychopharmacol (2015) 0.76
Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies. J Clin Pharm Ther (2014) 0.76
The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain. Oxid Med Cell Longev (2017) 0.75
Crucial roles of the CHRNB3-CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research. Transl Psychiatry (2016) 0.75
Orbitofrontal participation in sign- and goal-tracking conditioned responses: Effects of nicotine. Neuropharmacology (2016) 0.75
Layer-specific cholinergic control of human and mouse cortical synaptic plasticity. Nat Commun (2016) 0.75
Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors. Br J Pharmacol (2015) 0.75
CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation. Nicotine Tob Res (2016) 0.75
Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behav Pharmacol (2016) 0.75
Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation. Elife (2017) 0.75
Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry (1999) 5.63
A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol (1992) 3.20
International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev (1999) 2.76
Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science (1983) 1.78
Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry (2000) 1.68
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology (2001) 1.62
Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol (1998) 1.52
In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem (1985) 1.46
Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol (1995) 1.28
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther (1989) 1.10
[3H]cytisine binding to nicotinic cholinergic receptors in brain. Mol Pharmacol (1991) 1.09
Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem (1997) 1.07
Nicotinic cholinergic receptors labeled by [3H]acetylcholine in rat brain. Mol Pharmacol (1982) 1.06
Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol (1981) 1.04
Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science (1981) 1.02
Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain. Nature (1979) 1.02
Lithium: effects on serotonin receptors in rat brain. Eur J Pharmacol (1980) 1.01
[3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J Pharmacol Exp Ther (1995) 1.00
Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors. Neuropharmacology (1985) 1.00
Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Mol Pharmacol (2001) 1.00
Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology (Berl) (1987) 0.99
Neuronal nicotinic acetylcholine receptor alpha3 subunit protein in rat brain and sympathetic ganglion measured using a subunit-specific antibody: regional and ontogenic expression. J Neurochem (2001) 0.97
Dextromethorphan and its metabolite dextrorphan block alpha3beta4 neuronal nicotinic receptors. J Pharmacol Exp Ther (2000) 0.97
Acute effects of nicotine on prolactin release in the rat: agonist and antagonist effects of a single injection of nicotine. J Pharmacol Exp Ther (1990) 0.95
[125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J Pharmacol Exp Ther (1997) 0.95
Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem (1984) 0.95
Brainstem nicotinic receptor subtypes that influence intragastric and arterial blood pressures. J Pharmacol Exp Ther (2000) 0.95
Low nNOS protein in the locus coeruleus in major depression. J Neurochem (2004) 0.94
Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J Neurosci (1997) 0.94
Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology (1988) 0.93
Immobilized nicotinic receptor stationary phase for on-line liquid chromatographic determination of drug-receptor affinities. Anal Biochem (1998) 0.92
Experimental studies on the neurocardiovascular effects of urapidil. Drugs (1988) 0.92
Effects of long-term cigarette smoking on the human locus coeruleus. Arch Gen Psychiatry (2001) 0.91
The serotonin transporter in the midbrain of suicide victims with major depression. Biol Psychiatry (2000) 0.90
Autonomic nervous system actions of cardiac glycosides. Biochem Pharmacol (1978) 0.90
Activation and Ca2+ permeation of stably transfected alpha3/beta4 neuronal nicotinic acetylcholine receptor. Mol Pharmacol (1999) 0.89
Stimulation of serotonin2 receptors in the ventrolateral medulla of the cat results in nonuniform increases in sympathetic outflow. Circ Res (1990) 0.88
Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther (1979) 0.87
Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther (1990) 0.87
[3H]Tryptamine: high affinity binding sites in rat brain. Eur J Pharmacol (1982) 0.86
Evidence of a functional alpha7-neuronal nicotinic receptor subtype located on motoneurons of the dorsal motor nucleus of the vagus. J Pharmacol Exp Ther (2001) 0.86
Reductions in acetylcholine and nicotine binding in several degenerative diseases. Arch Neurol (1988) 0.86
Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res (1996) 0.85
Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine. Brain Res Mol Brain Res (1999) 0.84
Brain microvessels are innervated by locus ceruleus noradrenergic neurons. Neurosci Lett (1989) 0.84
Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience (1997) 0.84
Electroconvulsive shock but not antidepressant drugs increases alpha 1-adrenoceptor binding sites in rat brain. Eur J Pharmacol (1987) 0.84
A functional alternative splicing mutation in human tryptophan hydroxylase-2. Mol Psychiatry (2010) 0.83
Electroconvulsive shock and reserpine: effects on beta-adrenergic receptors in rat brain. J Neurochem (1981) 0.83
Liquid chromatographic studies with immobilized neuronal nicotinic acetylcholine receptor stationary phases: effects of receptor subtypes, pH and ionic strength on drug-receptor interactions. J Chromatogr B Biomed Sci Appl (1999) 0.83
Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res (1995) 0.83
Gestational nicotine exposure regulates expression of AMPA and NMDA receptors and their signaling apparatus in developing and adult rat hippocampus. Neuroscience (2011) 0.83
Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology (1999) 0.82
[125/123I] 5-Iodo-3-pyridyl ethers. syntheses and binding to neuronal nicotinic acetylcholine receptors. Nucl Med Biol (2001) 0.82
Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression. Brain Res (1999) 0.82
[3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain. Mol Pharmacol (1987) 0.82
Quantitative autoradiography of nicotinic [3H]acetylcholine binding sites in rat brain. Neurosci Lett (1984) 0.82
Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. J Neurosci (1990) 0.82
Neuropeptide Y in frontal cortex is not altered in major depression. J Neurochem (1995) 0.81
Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil. J Pharmacol Exp Ther (1989) 0.81
Axotomy and nerve growth factor regulate levels of neuronal nicotinic acetylcholine receptor alpha3 subunit protein in the rat superior cervical ganglion. J Neurochem (2001) 0.81
Selective increases in phosphoinositide signaling activity and G protein levels in postmortem brain from subjects with schizophrenia or alcohol dependence. J Neurochem (1998) 0.81
Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals. Am J Med (1984) 0.81
Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors. J Cardiovasc Pharmacol (1990) 0.80
Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders. J Neural Transm Suppl (1987) 0.80
[3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain. J Neurochem (1988) 0.80
In vivo regulation of the serotonin-2 receptor in rat brain. Life Sci (1986) 0.80
Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther (2001) 0.80
High-affinity binding of [3H]acetylcholine to muscarinic cholinergic receptors. J Neurosci (1985) 0.79
Origins of serotonin innervation of forebrain structures. Exp Neurol (1977) 0.79
Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Res (1989) 0.79
Pharmacology of neuronal nicotinic acetylcholine recceptors: effects of acute and chronic nicotine. Nicotine Tob Res (1999) 0.79
5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques. Neurosci Lett (2011) 0.78
Regulation of brain nicotinic cholinergic recognition sites and prolactin release by nicotine. Prog Brain Res (1989) 0.78
Serotonin involvement in pituitary-adrenal function. Ann N Y Acad Sci (1977) 0.78
Chronic reserpine administration selectively up-regulates beta 1- and alpha 1b-adrenergic receptors in rat brain: an autoradiographic study. Neuroscience (1992) 0.78
The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil. J Pharmacol Exp Ther (1991) 0.77
Electroconvulsive shock and reserpine increase alpha 1-adrenoceptor binding sites but not norepinephrine-stimulated phosphoinositide hydrolysis in rat brain. Eur J Pharmacol (1988) 0.77
[3H]acetylcholine binding sites in brain. Effect of disulfide bond modification. Mol Pharmacol (1983) 0.77
Characterization of [3H]tryptamine binding sites in brain. Eur J Pharmacol (1983) 0.77
Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat brain. Ann N Y Acad Sci (1986) 0.77
Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res (1990) 0.77
Effects of electroconvulsive shock on noradrenergic and serotonergic receptors in rat brain. Pharmacopsychiatry (1987) 0.77
Electroconvulsive shock increases alpha 1b- but not alpha 1a-adrenoceptor binding sites in rat cerebral cortex. J Neurochem (1991) 0.77
In vivo occupancy of dopamine receptors by antipsychotic drugs. Arch Gen Psychiatry (1992) 0.77
Role of alpha-2 adrenergic affinity in the action of a non-sedative antispasticity agent. Acta Neurol Scand (1982) 0.76
Electroconvulsive shock decreases beta-adrenoceptors despite serotonin lesions. Eur J Pharmacol (1988) 0.76
Electroconvulsive shock: effects on biochemical correlates of neurotransmitter receptors in rat brain. Neuropharmacology (1983) 0.76
In vivo labeling of nicotinic acetylcholine receptors in brain with [3H]epibatidine. Eur J Pharmacol (1995) 0.76
Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin. Neuroendocrinology (1992) 0.76
Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain. Eur J Pharmacol (1986) 0.76
Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain. J Neurosci (1990) 0.76